<SEC-DOCUMENT>0001279569-24-001141.txt : 20240920
<SEC-HEADER>0001279569-24-001141.hdr.sgml : 20240920
<ACCEPTANCE-DATETIME>20240920071942
ACCESSION NUMBER:		0001279569-24-001141
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240920
FILED AS OF DATE:		20240920
DATE AS OF CHANGE:		20240920

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AURORA CANNABIS INC
		CENTRAL INDEX KEY:			0001683541
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38691
		FILM NUMBER:		241311689

	BUSINESS ADDRESS:	
		STREET 1:		2207 90B STREET SW
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T6X 1V8
		BUSINESS PHONE:		604-362-5207

	MAIL ADDRESS:	
		STREET 1:		409 GRANVILLE STREET
		STREET 2:		SUITE 1700
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C 1T2
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>aurora_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>FORM 6-K</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>REPORT OF
FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<BR>
 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">For the month
of <B> September 2024</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Commission File
No. <B>001-38691</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 16pt"><B><U>AURORA
CANNABIS INC.</U></B></FONT><B><FONT STYLE="font-size: 10pt"><BR>
</FONT></B><FONT STYLE="font-size: 10pt">(Translation of registrant's name into English)</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>2207 90B St. SW <BR>
Edmonton, Alberta T6X 1V8 <BR>
Canada</B><U><BR>
</U>(Address of principal executive office)</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0"><FONT STYLE="font-size: 10pt">Indicate by check mark whether the
registrant files or will file annual reports under cover of Form 20-F or Form 40-F</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Form 20-F&nbsp;&nbsp;&#9744;
<B>Form 40-F&nbsp;&nbsp;&#9746;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>SUBMITTED HEREWITH</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; font: 12pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibits</B></FONT></TD>
    <TD STYLE="width: 2%"></TD>
    <TD STYLE="width: 90%; font: 12pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><A HREF="ex991.htm">99.1</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-transform: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-transform: none"><A HREF="ex991.htm">News
    Release dated September 20, 2024</A></FONT></TD></TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>AURORA CANNABIS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">/s/ <I>Miguel Martin</I></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><I></I><BR>
Miguel Martin<BR>
Chief  Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Date: September 20, 2024</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED SEPTEMBER 20, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT>&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 9pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 346.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 9pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 346.05pt"></P>

<P STYLE="font: 11pt/87% Tahoma, Helvetica, Sans-Serif; text-align: left; margin: 2.95pt 0 0 6pt"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 11pt/87% Tahoma, Helvetica, Sans-Serif; margin: 2.95pt 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora CEO Miguel Martin takes on additional
role as Executive Chairman of Board of Directors</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; text-align: right; margin-right: 0; margin-left: 0">NASDAQ | TSX: ACB</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; text-align: center; margin-right: 0; margin-left: 0"><B>Outgoing Chairman Ron Funk
appointed Lead Independent Director, as part of Board leadership transition</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">EDMONTON, AB, Sept. 20, 2024 /CNW/ - Aurora Cannabis
Inc. (the <B>&quot;Company&quot;</B> or <B>&quot;Aurora&quot;</B>) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis
company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron
Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Mr. Martin has served as Chief Executive Officer and
a director of the Company since September 2020 and will continue to serve as Chief Executive Officer. During this time, Mr. Martin has
driven significant change within the organization, including the financial recovery of the Company and successful business transformation,
all while leading with focus and integrity, and in the best interests of Aurora's shareholders. As a result, Aurora has been able to weather
much of the challenges that most in the cannabis industry have and continue to face. Having worked closely with and under the mentorship
of Mr. Funk, who served as Chairman of the Board of Directors (the &quot;Board&quot;) since 2021, the two are aptly positioned to continue
to effectively cultivate strong and unified Board leadership and governance as the Company enters its next stage of meaningful global
growth.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Board believes that combining the CEO and Chairman
roles will promote strong and consistent leadership, directional clarity, and effective and efficient decision making - all of which better
position Aurora to execute on its vision for global leadership.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;I am excited to take on this expanded role and
equally thrilled that we will have the ongoing benefit of Ron's extensive business experience, deep institutional knowledge and meticulous
Board leadership and governance expertise as Lead Independent Director,&quot; stated Miguel Martin, Executive Chairman and CEO of Aurora
Cannabis.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;It has been a pleasure both serving as Aurora's
Chairman of the Board, and working so closely with Miguel since he was appointed as CEO. I have no doubt that he will continue to effectively
lead and drive success in this expanded role for the benefit of our shareholders, and I look forward to our ongoing collaboration in my
role as Lead Independent Director,&quot; commented Ron Funk, Independent Director for Aurora Cannabis. &quot;Aurora's Board and leadership
team has evolved greatly over the past few years, enabled by thoughtful and strategic succession planning and all with a focus on what
is right for the Company and our shareholders. The future for Aurora is bright, and I am honoured to remain part of the Company's journey.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">In his expanded role as Executive Chairman, Mr. Martin
will lead in setting the Board agenda, drawing on his insight and understanding of Aurora's business and operations to identify strategic
opportunities and risk mitigation approaches for the Board's consideration. As Lead Independent Director, Mr. Funk will continue to be
focused on ensuring that the Board functions effectively and independently of management of the Company and on continuing to provide independent
leadership to the Board.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Company is also pleased to announce changes to
its Board committee compositions.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-bottom: 15pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 15pt">Michael Singer, who previously acted as Executive Chairman
and Interim CEO, is again considered independent within the meaning of National Instrument 52-110 -&nbsp;<I>Audit Committees</I>, as over
three years have elapsed since he resigned from the Executive Chairman position in May 2021. As a result, Mr. Singer has been appointed
to the Audit Committee and the Human Resource and Compensation Committee (&quot;<B>HRCC</B>&quot;), bringing invaluable expertise to both
committees. Both Mr. Singer and Audit Committee chair, Chitwant Kohli, are considered &quot;audit committee financial experts&quot; under
the rules of the SEC.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 15pt">Rajesh Uttamchandani has been appointed to the HRCC and the
Nominating &amp; Corporate Governance Committee, bringing his experience in human capital, strategy, governance and innovation which will
undoubtedly complement the existing strength of those committees.</FONT></TD></TR></TABLE>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Aurora</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora is opening the world to cannabis, serving both
the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer
in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael
'71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana
Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd.,&nbsp;North
America's&nbsp;leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality
cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets
wherever they are launched. Learn more at&nbsp;www.auroramj.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora's common shares trade on the NASDAQ and TSX
under the symbol &quot;ACB&quot;.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">This news release includes statements containing certain
&quot;forward looking information&quot; within the meaning of applicable securities law (&quot;forward-looking statements&quot;). Forward-looking
statements are frequently characterized by words such as &quot;plan&quot;, &quot;continue&quot;, &quot;expect&quot;, &quot;project&quot;,
&quot;intend&quot;, &quot;believe&quot;, &quot;anticipate&quot;, &quot;estimate&quot;, &quot;may&quot;, &quot;will&quot;, &quot;potential&quot;,
&quot;proposed&quot; and other similar words, or statements that certain events or conditions &quot;may&quot; or &quot;will&quot; occur.
Forward-looking statements in this news release include, but are not limited to, statements regarding the appointment of Miguel Martin
as Executive Chairman and associated benefits to the Company as well as the Company's future plans and expectations for global growth
and leadership.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">These forward-looking statements are only predictions.
Forward looking information or statements contained in this news release have been developed based on assumptions management considers
to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from market research and industry analysis and on assumptions based on data
and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events,
results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking
statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure
to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and
retention, the development of third party government and nongovernment consumer sales channels, management's estimates of consumer demand
in&nbsp;Canada&nbsp;and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful
integration of acquired business and operations, management's estimation that SG&amp;A will grow only in proportion of revenue growth,
the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions,
the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility
for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, and other risks, uncertainties
and factors set out under the heading &quot;Risk Factors&quot; in the Company's annual information form dated&nbsp;June 20, 2024&nbsp;(the
&quot;AIF&quot;) and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at&nbsp;www.sedarplus.com&nbsp;and
filed with and available on the SEC's website at&nbsp;www.sec.gov. The Company cautions that the list of risks, uncertainties and other
factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider
the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance
on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable
securities law.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-ceo-miguel-martin-takes-on-additional-role-as-executive-chairman-of-board-of-directors-302253802.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2024/20/c2249.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001683541</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>Contacts: For Media: Michelle Lefler, VP,
Communications &amp; PR, media@auroramj.com; For Investors: ICR, Inc., aurora@icrinc.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 07:00e 20-SEP-24</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  U 0,# 2(  A$! Q$!_\0
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M8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?!OCF>#]HJW\7^']=MX[:^M/$EC\-O MGK,T:17-TKZ?>W\$][ILQF,DUC/
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MSXN?L!P> /B+XZ\#0ZG\.?CY+J4/@_Q=X@\,Q:A+;>)OABEO+?1Z+J%DEW)
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M=8TN1]=M;77])%Y;2VDT]I+?Z?\ :8+BPNOWL<]NO^G!_P &YO\ P5*\8_\
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M0/\ A/=6N_C!\'_#/C?]F+XEZ_J%[>WOB+0O$WAZ*^C\!Z_+?SW\NJ:A+/\
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M\)8BO4I*AAL5&OFKS7,,51S.AA\!B<"J558F?]+OPW^&WP:\(6P\1_"3P/\
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M:Z=J?BOX=K>:#;74R(T4#:C#X5UPV_FNAE:R=(PY!V_@-_P:S_\ !3K]E/\
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MWB#Q1-K\WCG5O"6I6US8RZ+J=@EI'8)X<FBGCN%D:5KF-HV 1A6K_P $!?\
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M-M'U?_A,?#%W+>^ /'&AWNJSMI\&H:*FH>(M"U&&=3#?Z)XCNRZ/>Z?I<EN
M?QX?\'9&C:II?_!:_P"/]]J%C<6EIXC^&O[/6LZ'//%)'%J>EP?!WPIX>FOK
M-W55GMX]:T'6--:6(O&+O3[J L)89$7]_P#_ (-R_P#@O%_P33_91_X)J_#?
M]E#]J/XY7/P+^*GP;\3_ !:O+I/$_@/Q]KGA_P 7Z+XZ^)?B7XA:3JGA?6_
MWAOQ5:O+!;^*CH][I6K#2M3CO]+N9H;6>QGM;J;]\_\ @LI_P0R_9T_X*_\
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M2?VC_LB?!+4?V:_V4OV:_P!G76==L?%6J_ KX#?";X/ZIXETVRGT_3?$-_\
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M9;7#X@CNY3J46JQZDD=VO]?_ /P3\_X-"/B]^RC^VG^S=^TI\6OVI/@M\3_
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
